Our Pricing

Buy Semaglutide Injection UK - Prescription Weight Loss

Published on: June 03, 2026

Looking to buy semaglutide injection UK with a valid prescription? At Cured Pharmacy, we provide genuine UK-licensed semaglutide (Wegovy) from £79.00, with free clinical assessment by our UK-registered prescribers and discreet next-day delivery across the UK.

How Semaglutide Injections Work for Weight Loss

Semaglutide is a GLP-1 receptor agonist that mimics a naturally occurring hormone in your body called glucagon-like peptide-1 [1]. When you inject semaglutide once weekly, it activates GLP-1 receptors in the brain, pancreas, and digestive system, reducing appetite, slowing gastric emptying, and improving blood sugar regulation.

In the landmark STEP 1 clinical trial, adults using semaglutide 2.4mg achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. This represented the most significant weight loss outcomes seen in any GLP-1 medication trial at the time of publication, leading to MHRA approval of Wegovy for chronic weight management in the UK.

The medication works best when combined with a reduced-calorie diet and increased physical activity. Your UK prescriber will assess your BMI, medical history, and weight loss goals during your free consultation to determine if semaglutide is clinically appropriate for you.

Wegovy (Semaglutide) Dosing Schedule and Administration

Wegovy uses a gradual dose escalation protocol designed to minimise gastrointestinal side effects while optimising weight loss efficacy [2]. Treatment begins at 0.25mg weekly for four weeks, then increases monthly through 0.5mg, 1mg, and 1.7mg, before reaching the maintenance dose of 2.4mg weekly.

Each Wegovy pen is pre-filled and designed for single use with a hidden needle mechanism. You'll inject subcutaneously into your abdomen, thigh, or upper arm on the same day each week. The injection takes less than 30 seconds, and most patients report minimal discomfort after the first few administrations.

If you experience persistent nausea or vomiting during dose escalation, your prescriber may recommend staying at your current dose for an additional four weeks before increasing. This flexible approach, supported by NICE guidance, helps ensure treatment adherence whilst managing tolerability [3].

Storage and Handling Requirements

Unopened Wegovy pens must be stored in a refrigerator between 2°C and 8°C until first use. Once in use, pens can be kept at room temperature (up to 30°C) or refrigerated for up to 28 days. Never freeze semaglutide, and discard any pens that have been frozen, even if subsequently thawed.

Semaglutide vs Other Weight Loss Injections Available in the UK

The UK market now offers several injectable GLP-1 receptor agonists for weight management, each with distinct characteristics. Semaglutide (Wegovy) remains the most extensively studied single-pathway GLP-1 treatment, whilst newer dual-agonist medications target additional hormone pathways.

Liraglutide, marketed as Saxenda, was the first GLP-1 approved for weight loss in the UK but requires daily injections and produces more modest results. Clinical trials showed average weight loss of 8% with liraglutide compared to 14.9% with semaglutide over similar timeframes [1][4].

Tirzepatide represents a newer generation as a dual GIP/GLP-1 receptor agonist. In head-to-head SURPASS-2 trial data, tirzepatide demonstrated superior weight loss outcomes compared to semaglutide, though both medications require prescription assessment and are subject to individual clinical suitability [5].

Which Treatment Is Right for You?

Your choice between semaglutide and alternative weight loss injections depends on multiple factors including your BMI, previous treatment response, injection frequency preference, and budget. Our UK prescribers will discuss all licensed options during your free consultation, ensuring you receive the most clinically appropriate treatment for your circumstances.

Common Side Effects and How to Manage Them

Gastrointestinal side effects are the most frequently reported adverse events with semaglutide injections. In clinical trials, approximately 44% of participants experienced nausea, 24% reported diarrhoea, and 12% had vomiting, particularly during the initial dose escalation phase [1].

These side effects typically diminish within 4-8 weeks as your body adjusts to the medication. To minimise discomfort, eat smaller, more frequent meals, avoid high-fat foods, stay well-hydrated, and take your time when eating. If symptoms persist or worsen, contact your prescriber before your next scheduled dose increase.

Serious side effects are rare but require immediate medical attention. These include severe abdominal pain (potential pancreatitis), vision changes, persistent vomiting leading to dehydration, or signs of thyroid tumours such as a lump in the neck or difficulty swallowing. Semaglutide carries a black box warning regarding thyroid C-cell tumours observed in rodent studies, though no causal relationship has been established in humans [2].

Who Can Use Semaglutide Injection for Weight Loss in the UK

NICE guidelines recommend considering GLP-1 receptor agonists like semaglutide for adults with a BMI of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [3].

You cannot use semaglutide if you have a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, are pregnant or breastfeeding, or have severe gastrointestinal disease. Your prescriber will review your complete medical history, current medications, and any contraindications during your clinical assessment.

Treatment continuation depends on demonstrating adequate response. NICE recommends reviewing weight loss progress after 6 months, with continuation only if you've achieved at least 5% body weight reduction from baseline. Our clinical team monitors your progress through follow-up consultations to ensure ongoing suitability and efficacy.

Assessment Process at Cured Pharmacy

Our free online consultation takes under 3 minutes to complete and covers your medical history, current medications, weight loss goals, and any contraindications. A UK-registered prescriber reviews your assessment within 24 hours, and if clinically appropriate, issues a prescription for semaglutide. You'll see transparent pricing before completing your consultation, with no hidden fees.

Buy Semaglutide Injection UK: Pricing and Prescription Process

At Cured Pharmacy, Wegovy (semaglutide) is available from £79.00 per month, representing competitive UK pricing with transparent costs shown before your consultation. This includes the medication, UK prescriber assessment, and discreet delivery to your address.

All semaglutide injections are prescription-only medications in the UK, regulated by the MHRA. You cannot legally purchase semaglutide without a valid prescription from a UK-registered prescriber. Our online consultation ensures you receive the same clinical oversight as a face-to-face GP appointment, with full regulatory compliance.

After your prescriber approves your assessment, your medication is dispensed by our GPhC-registered pharmacy (registration 9012511) under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073). We dispatch via tracked courier in 100% discreet packaging, with most orders arriving next working day across the UK.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Davies, M., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0 [accessed 13 August 2026]
3. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity. Technology appraisal guidance [TA875]. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
4. Pi-Sunyer, X., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
5. Frías, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
6. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.